Streetbeat News

Regulatory

RDHL

RedHill Biopharma has announced additional U.S. Government funding for the development of Opaganib nuclear countermeasure. This news has led to an increase in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 11:45 am

BRTX

BioRestorative Therapies has received a license from the New York State Department of Health to operate as a tissue bank. This license allows the company to process mesenchymal stem cells obtained from autologous donors.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 11:14 am

BMY

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended approval of Bristol Myers Squibb's Opdivo (Nivolumab) as a monotherapy for the adjuvant treatment of adults and adolescents with completely resected stage IIB or IIA melanoma.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 11:02 am

BTCUSD

COIN

ETHUSD

Coinbase has announced that it will fully shut down its Borrow Lending Program in November. This comes after the company faced regulatory scrutiny from the SEC over the program.

Portfolio Pulse from Charles Gross

July 21, 2023 | 10:33 am

AN

GM

JNJ

TSM

Investor sentiment declines as Nasdaq falls 2%. Cathie Wood's Ark Invest reduces GM stake and buys more Taiwan Semiconductor shares. UK Finance Ministry disagrees with calls to regulate crypto as gambling. CoinDesk is on the verge of a $125M acquisition. Microsoft-Activision deal may be heading towards settlement talks. AutoNation expected to report lower Q2 earnings. Starbucks partners with K-Pop stars BLACKPINK for potential sales boost. J&J investors will soon be able to exchange shares for Kenvue stocks.

Portfolio Pulse from Akanksha Bakshi

July 21, 2023 | 10:24 am

AAPL

GOOGL

Google's Play Store commissions are under increasing scrutiny by regulators worldwide. The company has been fined $10.63 billion since 2017 for its billing systems and anti-competitive practices. Regulators in Australia, India, and South Korea are considering laws to allow app developers to offer in-app purchases without cutting their earnings to Google and Apple. In India, Google has been directed to charge a lower commission of 4% on in-app purchases in the Disney+ Hotstar app.

Portfolio Pulse from Rounak Jain

July 21, 2023 | 10:22 am

MRTX

Mirati Therapeutics has received a negative opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on its application for conditional marketing authorization for KRAZATI (Adagrasib) for patients with KRASG12C-mutated advanced non-small cell lung cancer. Mirati disagrees with the opinion and plans to request a formal re-examination.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 10:21 am

EBS

The FDA has approved Emergent BioSolutions Inc's (NYSE:EBS) two-dose anthrax vaccine, Cyfendus, for adults aged 18 through 65. The vaccine is approved for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis. The U.S. government has been procuring this product for national preparedness efforts since 2019. Following the announcement, EBS shares jumped 17.28% in premarket trading.

Portfolio Pulse from Vandana Singh

July 21, 2023 | 10:15 am

JPM

JP Morgan is planning to launch its online banking platform, Chase, in Germany and other EU countries. This move is part of the bank's strategy to expand its digital footprint in Europe.

Portfolio Pulse from Charles Gross

July 21, 2023 | 9:52 am

FXI

SPY

China's State Financial Regulatory Administration is drafting rules to allow multinational groups to directly initiate the establishment of foreign-funded financial companies. This move could potentially open up China's financial sector to more foreign investment.

Portfolio Pulse from Charles Gross

July 21, 2023 | 9:27 am